Want to keep yourself up to date with the latest news from Eurasia Business News?
Subscribe using the "Follow" button below and we provide you with customized updates, via topic or tag, that get delivered to your email address, your smartphone or on your dedicated news page on follow.it.
You can unsubscribe at any time painlessly.
Title of Eurasia Business News: "Eurasia Business News – News that matter – L'actualité qui compte"
Is this your feed? Claim it!
By John Meyer, consultant in financial affairs – Eurasia Business News, August 19, 2026. Article No 3108
The U.S. national debt has surpassed $40 trillion, marking a historic milestone in federal borrowing and intensifying concerns about budget deficits, interest costs and long-term economic stability. Treasury Department data showed total public debt outstandin...
By William Collins, consultant in stock markets – Eurasia Business News, August 19, 2026. Article no 3107
U.S. stock markets closed modestly higher on August 19 after the Treasury Department announced a major expansion of its long-term government bond repurchase program. The move pushed Treasury yields lower and provided relief to equity investors after long-ter...
By Swann Collins, investor, writer and consultant in international affairs – Eurasia Business News. August 19, 2026. Article no 4006.
View on the towers of Moscow City, from the Borodinsky Brigde, Moscow – January 2022. Photo credits : Swann Collins.
Russia’s economy is expected to grow slowly in 2026 and 2027 as high inflation, elevated inter...
By John Meyer, consultant in financial affairs – Eurasia Business News, August 19, 2026. Article No 4003
The U.S. Treasury Department will expand its long-term bond buyback program after a sharp rise in borrowing costs pushed the 30-year Treasury yield to its highest level since 2007. The move is intended to improve liquidity in longer-dated government debt, sup...
By William Collins, consultant in stock markets – Eurasia Business News, August 19, 2026. Article no 4005
Moderna shares nearly doubled on August 19 after the biotechnology company and Merck announced positive Phase 3 results for their personalised mRNA cancer vaccine in high-risk melanoma patients. The breakthrough represents the first successful late-stage stu...